Nanostructured drug delivery systems are formulations containing particles usually fabricated with polymers. They can be administered by all drug routes (depending on their characteristics) and in various pharmaceutical forms, including nanoemulsions, nanosuspensions, nanofilms and lyophilized powders. The size, shape and surface load influence the functionality of nanoparticles, as well as their stability.
Introduction
C-Phycocyanin (C-FC) is a water-soluble blue protein pigment that, together with Chlorophyll, captures light for photosynthesis in cyanobacteria. C-FC has several applications in the pharmaceutical area as natural food coloring, fluorescent marker applied to medical diagnosis and immunological assays. 1 In addition to commercial uses, the protein has widely described antitumor potential. However, this potential demands more robust formulations for protein stability and release. Nanoparticles of chitosan and alginate, for example, potentiate the action of the antimicrobial protein nisin for food preservation. The nanoparticles of chitosan crosslinked with tripolyphosphate are reproducible, scalable and with great capacity of encapsulation of active principles, reason why was chosen for this project.
In view of this, this study consists of the pharmacotechnical development of chitosan nanostructured formulations, cross-linked with sodium tripolyphosphate (TPP), for incorporation and subsequent sustained release of C-FC. 
Results and Discussion
In order to identify the best formulation incorporated with C-FC, a complete factorial design of three factors and two levels with center point was carried out and formulations were analyzed in relation to size and zeta potential by Dinamic Light Scattering (DLS), Zetasizer Nano ZS, Malvern Instruments Ltd, Malvern, England and by Nanoparticle Tracking Analysis (NTA), Nanosight, Malvern Instruments Ltd, Malvern, England).
The critical parameters studied were chitosan concentration, TPP concentration and rotation (rpm).
The DLS calculates the Brownian motion for the resulting fluctuations of diffraction intensity of the laser at an angle and for a set of particles while the NTA records this motion by image and for each particle. The chitosan nanoparticles are formed by ionic gelation, based on the electrostatic interaction between chitosan and TPP.
In Table 1 below, it can be observed that formulation 6 (F6) was the one that obtained the best results, in both Average size (212 ± 6,5nm), PDI (0,252) and Zeta potential (27,9 ± 1,11mV) . But even so, in a period of 7 days there was also precipitation of the formulation 6. Table 1 . Nanopaticles with C-phycocyanin: 2 3 factorial design with central point. Table 2 . Results by NTA of formulation 6.
In Table 2 , when analyzed the results of the NTA, we can verify that through this technique the average sizes of the nanoparticles are well below compared to the DLS.
Conclusions
Although some formulations precipitated, there was no direct correlation with one of the factors evaluated. The best performance formulation was 1,5 mg/mL chitosan, 0,75 mg / mL TPP and 1000 rpm agitation, with a mean size of 212,0 ± 6.5 nm, PDI of 0.252 (desirable = the lowest) and Zeta potential of 27.9 ± 1.1mV (desirable ~ 30). ______________________________________________
